For Southern United States FamiliesEarly Alzheimer's Evaluation in Cuba in Southern United States
The Southern United States — including Texas, Oklahoma, Louisiana, Mississippi, Florida, and South Carolina — is home to over 1.4 million Americans living with Alzheimer's. The region's large and diverse population, significant African American and Hispanic communities, and high diabetes prevalence create a compounding risk for cognitive decline. Houston and Miami offer direct charter flights to Havana, while Dallas, Oklahoma City, and New Orleans provide connecting flight options.
1.4M
Southern United States residents with Alzheimer's
6
states in region
1–6 hours (varies by departure city)
to Havana
Direct
flights available
Why Early Evaluation Matters Across Southern United States
Early evaluation is one of the most powerful tools in Alzheimer's care. The Alzheimer's Association emphasizes that early and accurate diagnosis can help patients explore treatment options, maintain independence longer, participate in clinical trials, and plan for the future while they still can. In the United States, however, comprehensive early evaluation is often limited by insurance coverage and appointment availability.
Cuba's early evaluation program is designed for patients with mild cognitive impairment (MCI) or early-stage Alzheimer's disease. The evaluation includes detailed neuropsychological testing to distinguish normal aging from MCI and early Alzheimer's, brain MRI to assess hippocampal atrophy and other early markers, blood work to rule out reversible causes of cognitive decline, and a comprehensive multidisciplinary team assessment.
Following the evaluation, the medical team provides a personalized treatment plan that may include NeuroEPO research (available for mild cognitive impairment and mild Alzheimer's), intensive cognitive rehabilitation (most effective when started early, when neuroplasticity is greatest), pharmacological management, and caregiver education. Early intervention offers the best opportunity to slow cognitive decline and maintain function — though no treatment currently cures Alzheimer's, and individual outcomes vary.
No treatment currently cures Alzheimer's disease. Cuba's program aims to slow cognitive decline, maintain function, and improve quality of life. NeuroEPO is investigational and not FDA-approved. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.
State-by-State Guides
Early Alzheimer's Evaluation in Cuba by State in Southern United States
Select your state for detailed information about early alzheimer's evaluation in cuba options, travel logistics, and state-specific resources.
City-Level Guides
Early Alzheimer's Evaluation in Cuba by City in Southern United States
Travel from Southern United States
Getting to Havana from Southern United States
Major Departure Airports
- Miami (MIA)
- Tampa (TPA)
- Houston (IAH)
- Dallas (DFW)
- New Orleans (MSY)
- Oklahoma City (OKC)
Travel time: 1–6 hours (varies by departure city)
Travel Authorization
- • U.S. citizens can travel to Cuba under approved categories
- • SMC Salud provides letter of medical necessity
- • Treatment confirmation documentation included
- • Airport reception and ground transport in Havana
- • English-speaking coordinators throughout your stay
Frequently Asked Questions
Questions from Southern United States Families
Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.
Ready to Explore Early Alzheimer's Evaluation in Cuba in Cuba?
Submit your medical records for a complimentary review. Families across Southern United States receive a personalized treatment proposal within 5–10 business days.